This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million. CI
Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023 CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Huaxia Eye Hospital Group Co.,Ltd.'s Equity Buyback Plan announced on January 9, 2024. CI
Huaxia Eye Hospital Group Co.,Ltd. announces an Equity Buyback for CNY 250 million worth of its shares. CI
Huaxia Eye Hospital Group Co.,Ltd. authorizes a Buyback Plan. CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component Index CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component A Share Index CI
Huaxia Eye Hospital Chairman, Actual Controller Detained for Personal Reasons MT
Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2023. CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to S&P Global BMI Index CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire an additional 33% stake in Hefei Shining Eye Hospital Co., Ltd from Anhui Zhongshi Ophthalmologists Group Management Partnership Enterprise (Limited Partnership), Hefei Aiweixi Eyewear Co., Ltd., Anhui Shining Hospital Management Co., Ltd. and Chen Linyi for CNY 70 million CI
Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 11, 2023 CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to FTSE All-World Index CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Huaxia Eye Hospital Group Co.,Ltd. has completed an IPO in the amount of CNY 3.0528 billion. CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Huaxia Eye Hospital Group Co.,Ltd.
More charts
Huaxia Eye Hospital Group Co Ltd is a China-based company mainly engaged in ophthalmic medical business. The Company's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The Company is also engaged in glasses and pharmacy retail business. The Company mainly conducts its business in the domestic market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
26.26 CNY
Average target price
50.02 CNY
Spread / Average Target
+90.48%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301267 Stock
  4. News Huaxia Eye Hospital Group Co.,Ltd.
  5. Huaxia Eye Hospital Chairman, Actual Controller Detained for Personal Reasons
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW